Fujifilm Fellowship Fund
at Harvard Medical School
Benefactor Report
May 2026
Since 2019, Fujifilm has committed $5 million to the Fujifilm Fellowship Fund, which has played a pivotal role in the growth and impact of the Therapeutics Graduate Program (TGP), a training program that focuses on pharmacology, toxicology, and drug discovery, with an emphasis on research in both HMS labs and real-world internships.
The Fujifilm Fellowship awards up to two years of research funding to promising PhD students across 14 programs spanning HMS, the Harvard Kenneth C. Griffin Graduate School of Arts and Sciences, and the Harvard T. H. Chan School of Public Health. In addition to their PhD programs, Fujifilm Fellows are enrolled in the TGP, which provides the scientific, laboratory, computational, and professional skills needed to excel in academic and biopharmaceutical careers in therapeutic science, and offers an engaged community to support the fellows’ development. The TGP emphasizes research in labs across Harvard and its affiliate institutions and hospitals, as well as in internships at other institutions.
The profiles below highlight the 2025–2026 recipients of Fujifilm Fellowships and represent this year’s support. The full history of the program and profiles of all Fellows to date can be found on the program website; with the present cohort, HMS has now awarded Fujifilm Fellowships to 41 students in total.
2025–2026 Fujifilm Fellows
Yossef Baidi
A Fujifilm Fellow in the Rameen Beroukhim lab at Dana-Farber Cancer Institute and the Broad Institute, Yossef studies adult and pediatric brain cancers and investigates how structural variants in these cancers can serve as driver events and influence treatment responses.
"I feel honored to be a Fujifilm fellow at Harvard this year! This fellowship has allowed me to focus completely on my research. I am investigating how the loss of the CDKN2A/B tumor suppressor locus impacts glioblastoma formation and treatment response. Additionally, I was able to present this work at the Society for Neuro-Oncology annual meeting, the largest meeting for researchers studying brain cancers, and get feedback from leading experts in the field."
—Yossef Baldi
HyoJeon Kim
A Fujifilm Fellow in the Philip Cole lab in the HMS Department of Biological Chemistry and Molecular Pharmacology, HyoJeon studies the chemical biology of protein post-translational modifications, particularly ubiquitination.
"Being a Fujifilm Fellow this year meant a lot to me, especially in the context of ongoing funding cuts at Harvard. The fellowship provided crucial support that allowed me to keep my research moving forward during an uncertain time. I was also honored to present my work at the 2025 TGP symposium and to be part of such an engaged and collaborative scientific community."
—HyoJeon Kim
In his role as a Fujifilm Fellow in Tim Mitchison's lab in the HMS Department of Systems Biology, Boyan studies the pharmacokinetics and pharmacodynamics of microtubule drugs, using a combination of experimental cell and chemical biology and mathematical modeling.
Boyan Li
Ruitong Li
As a Fellow in Gad Getz's lab at the Broad Institute, Ruitong studies the interplay of genetic and epigenetic factors associated with cellular phenotype shifts using single-cell omics data. She completed her PhD studies this February and has taken a position as a postdoctoral fellow at AITHYRA, the Research Institute for Biomedical Artificial Intelligence of the Austrian Academy of Sciences.
Nikola Mizgier
In Karen Adelman's lab in the HMS Department of Biological Chemistry and Molecular Pharmacology, Nikola focuses on the mechanisms of transcription regulation and their implications in disease.
"Having the support of the Fujifilm Fellowship this year has made a real difference in my research training. Broadly, my work focuses on characterizing transcriptional regulators that could serve as potential drug targets for treating cancer and developmental disorders. By supporting this research, Fujifilm helps bridge basic science with practical innovation in drug development, which makes my work feel more impactful and motivates me to keep pushing forward. The fellowship has also connected me with a community of like-minded students, providing opportunities to exchange ideas, stay engaged with related research across campus, and explore potential collaborations. I really appreciate the support and encouragement!"
—Nikola Mizgier
A Fujifilm Fellow in Lisa Goodrich's lab in the HMS Department of Neurobiology, Cynthia studies spiral ganglion neurons, which transmit sound information from the ear to the brain.
Cynthia Moncada-Reid
"Being a Fujifilm Fellow this year has been really meaningful to me. I’m a fifth-year PhD student in the Goodrich lab studying transcriptional mechanisms in neurons, and being selected for this fellowship gave me a major confidence boost at a pivotal point in my training. Fujifilm’s support has enabled me to pursue experiments that are fundamental to my thesis work without compromising scope or quality. Beyond the practical support, it’s been motivating to feel seen and connected to the scientific community. I’m very grateful for Fujifilm’s commitment to supporting early-career scientists and foundational research."
—Cynthia Moncada-Reid
Zachary "Zack" Murphy
Working in Tracy Young-Pearse's lab at Brigham and Women's Hospital, Zack examines the molecular and cellular roles of XX and XY chromosome complements in Alzheimer’s disease.
"This past year has been tough, fraught with uncertainty throughout the scientific community and especially here at Harvard. Not knowing whether my lab, program, or school would receive funding, or for how long, weighed on me. So, this year, more than most, I was immensely honored and thankful to be selected as a Fujifilm Fellow for the 2025–2026 year. This fellowship has provided certainty and allowed me to focus on conducting rigorous and innovative science in a distraction-free environment. Thank you, Fujifilm; the Fujifilm Fellowship Program has truly made a difference in my graduate school career, and I am sure my peers in the Fujifilm Fellowship Program would say the same."
—Zack Murphy
A Fujifilm Fellow in Gad Getz's lab at the Broad Institute, Sherin studies immune resistance in kidney cancer patients undergoing immunotherapy.
Simayijian "Sherin" Xirenayi
"I was truly honored to be selected as a Fujifilm Fellow and am very grateful for the recognition. I’ve seen many graduate students I admire receive this fellowship, so being nominated myself was both rewarding and motivating. This support has encouraged me to keep striving to do impactful work, especially as I focus on identifying new therapeutic targets and strategies to improve outcomes for patients with kidney cancer."
—Sherin Xirenayi
Fujifilm Fellowships 2019–2026
- Dana-Farber Cancer Institute (11)
- HMS Department of Biological Chemistry & Molecular Pharmacology (10)
- HMS Department of Systems Biology (6)
- Brigham and Women’s Hospital (6)
- Harvard Faculty of Arts and Sciences (6)
- Broad Institute (5)
- Massachusetts General Hospital (3)
- HMS Department of Neurobiology (2)
- HSPH Department of Immunology & Infectious Diseases (2)
- HMS Department of Genetics (2)
- Boston Children’s Hospital
- Wyss Institute at Harvard
- HMS Center for Computational Biomedicine
- Harvard Department of Stem Cell & Regenerative Biology
- HMS Department of Microbiology
- HSPH Department of Environmental Health
- HMS Department of Cell Biology
DISTRIBUTION OF FUJIFILM FELLOWS ACROSS HARVARD DEPARTMENTS AND AFFILIATES
POSTGRADUATE PLACEMENTS FOR FUJIFILM FELLOWSHIP ALUMNI
- Harvard Medical School
- Harvard T.H. Chan School of Public Health
- The Broad Institute
- Brigham and Women’s Hospital
- Massachusetts General Hospital
- Beth Israel Deaconess Medical Center
- Dana-Farber Cancer Institute
- University of California, San Francisco
- Align Foundation
- Aarhus University
- AITHYRA, the Research Institute for Biomedical Artificial Intelligence of the Austrian Academy of Sciences
17
Harvard Departments
and Affiliates
11
Academic Institutions
- Formation Bio
- Chiesi USA, Inc
- Pfizer
- Monimoi Therapeutics
- Solasta Ventures
- Axiom Healthcare Strategies
- Kx Advisors
- Novartis Venture Fund
- Leerink Partners
- Piper Sandler